Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ClearSight NextGen1 Study

NCT: NCT07317648 · COMPLETED

NCT IDNCT07317648
StatusCOMPLETED
Start Date2025-10-16
Completion2026-03-05
SponsorBecton, Dickinson and Company (INDUSTRY)
First posted
Last updated

Brief Summary

A prospective, non-randomized single arm study using the investigational ClearSight NextGen (CSNG) system in adult subjects.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑